|
CELF1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.555480E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.46829999999143E-05 |
| Normal-vs-Stage2 |
1.522230E-01 |
| Normal-vs-Stage3 |
8.590300E-02 |
| Normal-vs-Stage4 |
4.39800000000545E-05 |
| Stage1-vs-Stage2 |
4.688800E-01 |
| Stage1-vs-Stage3 |
4.003600E-01 |
| Stage1-vs-Stage4 |
2.880400E-01 |
| Stage2-vs-Stage3 |
9.972800E-01 |
| Stage2-vs-Stage4 |
1.656960E-01 |
| Stage3-vs-Stage4 |
1.358030E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.813300E-04 |
| Normal-vs-AfricanAmerican |
5.556200E-03 |
| Normal-vs-Asian |
1.793420E-01 |
| Caucasian-vs-AfricanAmerican |
9.622200E-01 |
| Caucasian-vs-Asian |
7.588200E-01 |
| AfricanAmerican-vs-Asian |
7.425800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.50043999999072E-05 |
| Normal-vs-Female |
2.913800E-01 |
| Male-vs-Female |
2.027700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.418160E-03 |
| Normal-vs-Extreme_Weight |
3.78260000000186E-06 |
| Normal-vs-Obese |
5.826200E-02 |
| Normal-vs-Extreme_Obese |
1.445210E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.183800E-01 |
| Normal_Weight-vs-Obese |
1.542760E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.535600E-01 |
| Extreme_Weight-vs-Obese |
3.538100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.866600E-01 |
| Obese-vs-Extreme_Obese |
6.873200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.467400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.264400E-02 |
| Normal-vs-Age(61-80Yrs) |
3.21530000002568E-06 |
| Normal-vs-Age(81-100Yrs) |
3.222000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.868600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.996200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.796060E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.960130E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.005800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.567200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.823000E-04 |
| Normal-VS-Type2 PRCC |
1.030410E-04 |
| Normal-VS-KIRP CIMP |
4.400000E-01 |
| Normal-VS-Unclassified PRCC |
6.011000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.059800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.325600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.202190E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.243200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.332500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.254200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.85510000000533E-06 |
| Normal-vs-N1 |
3.531200E-01 |
| Normal-vs-N2 |
1.292440E-02 |
| N0-vs-N1 |
4.795700E-02 |
| N0-vs-N2 |
8.402800E-01 |
| N1-vs-N2 |
3.190200E-01 |
|
|
